about
sameAs
Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatomaHib Vaccines: Past, Present, and Future PerspectivesCell factories for insulin productionElevated Concentration of Defensins in Hepatitis C Virus-Infected PatientsProduction of Biopharmaceuticals in E. coli: Current Scenario and Future PerspectivesAdjuvants for Clostridium tetani and Clostridium diphtheriae vaccines updating.Therapeutic alpha-interferons protein: structure, production, and biosimilar.Unstructural biology of the Dengue virus proteins.Antimicrobial potentials and structural disorder of human and animal defensins.A Metagenomics Investigation of Carbohydrate-Active Enzymes along the Gastrointestinal Tract of Saudi SheepScreening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.Auto-induction expression of human consensus interferon-alpha in Escherichia coliEffectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.Animal-derived pharmaceutical proteins.Influence of camel milk on the hepatitis C virus burden of infected patients.Potential lactoferrin activity against pathogenic viruses.Human consensus interferons: Bridging the natural and artificial cytokines with intrinsic disorder.Comparative Analysis of the Antiviral Activity of Camel, Bovine, and Human Lactoperoxidases Against Herpes Simplex Virus Type 1.Virucidal activity of human α- and β-defensins against hepatitis C virus genotype 4.Erythropoietin and co.: intrinsic structure and functional disorder.Expression, purification, and characterization of recombinant human consensus interferon-alpha in Escherichia coli under λP(L) promoter.Status of diphtheria immunity in the Egyptian population.Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells.Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and hela cell lines.Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells.Biocidal activity of chicken defensin-9 against microbial pathogens.Virucidal activity of cell-penetrating peptides of viral origin.In vitro exploration of the anti-HCV potential of the synthetic spacer peptides derived from human, bovine, and camel lactoferrins.Significant antibacterial activity and synergistic effects of camel lactoferrin with antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).Expression and Purification of C-Peptide Containing Insulin Using Pichia pastoris Expression System.Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.Structure determination of a cocaine hydrolytic antibody from a pseudomerohedrally twinned crystal.Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems.Expression and characterization of a humanized cocaine-binding antibody.Ovine anti-rabies antibody production and evaluation.Production and purification of ovine anti-tetanus antibody.Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.The anti-cancer activity of human consensus interferon-alpha synthesized in cell-free system.Comparison between therapeutic antitoxin F(ab)2 fractionated with ammonium sulfate and caprylic acid.Not all AMLETs are made equal: Complexes of cow and camel α-lactalbumin with oleic acid show different structure and stability.
P50
Q21245093-546CE6FC-EE7F-4D38-9FF1-4100B04E418BQ26767144-1B80F009-094E-467D-AEC8-BCC1960E7D24Q27000550-2592D88C-0BD8-49D2-A3F4-2D184933326EQ27000550-3F0C92C9-06A9-4411-AC7F-1FAC8EF04A38Q27469045-F414B7B5-8133-467E-B7A9-928DF6794DBFQ28083443-697E527D-7E12-4ABA-B937-EB29C6C11D80Q28083443-E9101643-E842-48C1-BDFD-32F4EAD0017AQ30241084-7B707D2C-D6D2-435E-AD64-16C33D352834Q30361968-6BE0379A-9354-400A-B71B-7681B443C2F2Q30361968-EC7CE0D2-8B20-46D5-A5B3-B203C35927CCQ30375946-862F7BBB-9717-4DE5-A0DA-3AF6996FB77AQ30375946-B9DA1CB7-567B-4AFA-9331-A749C3BD7154Q30381764-8F32C5FC-36C6-4757-83B4-1B7403B03138Q30381764-B151857E-7B29-4F97-A40F-67DE4F9AA542Q33580869-C7C2BF62-C167-4525-8201-44880471AE8BQ33863096-A0EEA4C0-424B-43AC-9AC1-7FC911BDD987Q33863096-F794C255-5E06-444E-BAA4-E4DD76C24622Q35607025-30F1D9D3-E84B-4EF2-8C58-A6EF44F28BC4Q35607025-8F30CF28-38F6-4491-8075-7AEE1C22A93CQ36958593-1C82DD85-C0D0-4227-B8AE-94D591C515CEQ36958593-C9AA72C7-8BA3-4EB1-9448-421060669F91Q37547045-1D6B1361-5506-421F-A5DD-1CCFC1889B68Q37547045-91AC8779-A320-4B9E-88FA-F42628220739Q37734598-8BB6411E-5EB8-481B-9453-D54C81815114Q38256680-66FAC041-1DDE-477D-9971-E26CBA118CE9Q38256680-D28FFC17-2BDE-4529-8B6E-AC2C6F46E5D8Q38546351-2B0AC499-47B4-4105-9FCF-E7DD56D8A43BQ38546351-C93B9836-F888-4BB3-AC6F-F1034D75525BQ38730749-CB66F05B-5C5C-45D8-9A32-4F7F6BE74741Q38763073-052BB2F4-7639-420F-AECA-12FD7E306797Q39005050-EE7AA6A6-5E8C-4229-85D3-AF7DC9E1057BQ39296553-05225626-51C2-473A-88B5-F09B9E15E2FFQ39296553-13DD5BAC-A663-4137-84E1-EB76E961C75DQ39389141-2C71BEEE-C3B3-4401-BB88-3EA33F0D143AQ39389141-DEFBB964-A915-4DD4-8DDD-F09D459CDEFDQ39448150-553E77A2-713A-4B39-98BD-428C389BB0B9Q39448150-9BBA6DAD-AD38-47E3-86D2-5D29F20ADE8DQ39701870-4421A74C-90EE-4921-87AE-90028437D7C5Q39701870-6758404E-DA7F-4B98-B722-861F69C82CA5Q39739401-A4CB60E6-5543-4927-9B1D-2E8AAC810F2C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elrashdy Moustafa Redwan
@ast
Elrashdy Moustafa Redwan
@en
Elrashdy Moustafa Redwan
@es
Elrashdy Moustafa Redwan
@sl
type
label
Elrashdy Moustafa Redwan
@ast
Elrashdy Moustafa Redwan
@en
Elrashdy Moustafa Redwan
@es
Elrashdy Moustafa Redwan
@sl
altLabel
Elarshdy Redwan
@en
Rashdy
@en
prefLabel
Elrashdy Moustafa Redwan
@ast
Elrashdy Moustafa Redwan
@en
Elrashdy Moustafa Redwan
@es
Elrashdy Moustafa Redwan
@sl
P1053
I-1769-2012
P106
P1153
8519808500
P31
P3829
P496
0000-0001-8246-0075
P569
2000-01-01T00:00:00Z